Odyssey Therapeutics, Inc. has set terms for its initial public offering, marketing 13.24 million sh...

Hemab Therapeutics Holdings, Inc. (NASDAQ: COAG) has set terms for its initial public offering, mark...

Avalyn Pharma Inc. (Nasdaq: AVLN) has filed to raise approximately $200 million in its upcoming IPO,...

X-Energy, Inc. (“XE”) has set terms for its initial public offering, planning to offer 42.9 million ...